Leadership & People
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Executives On The Move: Arvinas Nabs New Chief Financial Officer From Intercept Pharmaceuticals
Recent moves in the industry include changes at the top for Sumitomo Pharma, ASKA and Takeda, plus Maat Pharma gets a new chief medical officer.
Parexel Execs On Obesity Drug Hurdles, Parexel GPT, India RWD Opportunity
Parexel’s chief strategy officer Kushal Gohil, Clinical EVP Stephen Pyke and India head Sanjay Vyas share thoughts on possible hurdles to, and the cascading impact of obesity treatments, GenAI progress and the opportunities and challenges of real-world data in India, in the second of this two-part interview with Scrip.
Titans Of Pharma: J&J Back On Top For CEO Remuneration
J&J topped the league table for CEO pay in 2023, a position it has held for three of the four past years. Meanwhile, the two companies that arguably generated the most buzz in 2023 neatly depict the stark contrast between the US and Europe when it comes to executive remuneration.
Executives On The Move: New Hires At Eisai, Connect Biopharma, Actylis And More
Recent moves in the industry include new chief executive officers at Connect Biopharma, Skyhawk Therapeutics and Actylis, plus I-Mab gets new chief medical officer.
Podcast: Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond
In this podcast, Janelle Hart, Managing Editor, Citeline, joins together with industry experts, Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Associate Director of FSS Operations, both from Advanced Clinical, to discuss the latest trends and challenges in building, scaling and differentiating workforces in the life sciences sector.
Executives On The Move: Three New CFOs And One New CEO Among This Week's Changes
Recent moves in the industry include C-suite shuffles at MorphoSys, Centessa Pharmaceuticals and Skyhawk Therapeutics, plus bluebird bio acquires a new chief financial officer.
Astellas’s US Commercial Head Petroutsas On New Launches
The Japanese pharma’s new US commercial head Michael Petroutsas talked to Scrip about the launches of Veozah and Izervay.
Executives On The Move: Assertio Holdings Acquires Chief Executive Officer from Glenmark Pharmaceuticals
Recent moves in the industry include changes at the top for Inhibrx and Monte Rosa Therapeutics, plus Imunon, Avrobio and Kronos Bio acquire chief financial officers from Cyteir Therapeutics, Oyster Point Pharma and Senti Biosciences, respectively.
Amid Talk Of KKR Stake Sale, JB CEO Stresses Business As Usual
In an interview with JB CEO Nikhil Chopra, Scrip discusses talk of a stake sale by private equity fund KKR, gains from acquisitions including select Novartis brands, plans to ascend to the top five in cardiology and a ramp up of the CDMO business, which has clients including J&J.
Executives On The Move: Eight New C-Suite Appointments Among This Week's Changes
Recent moves in the industry include C-suite shuffles at Cosmo Pharmaceuticals and Nurix Therapeutics, as Cosmo Pharmaceuticals gets a new chief executive officer.
Executives On The Move: Ocular Therapeutix Hooks ChIef Medical Officer From Beacon
Recent moves in the industry include C-suite shuffle at Senti Biosciences, plus BioMarin Pharmaceutical gets new chief commercial officer.
AstraZeneca Targets $80bn Sales By 2030 But Analysts Still To Be Convinced
The UK company has unveiled a new strategy for 2030 and beyond but analysts' forecasts fall around $15bn short of the company’s own projections.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.